ATE302265T1 - Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon - Google Patents

Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon

Info

Publication number
ATE302265T1
ATE302265T1 AT02785202T AT02785202T ATE302265T1 AT E302265 T1 ATE302265 T1 AT E302265T1 AT 02785202 T AT02785202 T AT 02785202T AT 02785202 T AT02785202 T AT 02785202T AT E302265 T1 ATE302265 T1 AT E302265T1
Authority
AT
Austria
Prior art keywords
composition containing
lactobacillus strain
thrush
tract
employed
Prior art date
Application number
AT02785202T
Other languages
English (en)
Inventor
Anthony G Wynne
Glenn R Gibson
Jonathan Brostoff
Original Assignee
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Reading filed Critical Univ Reading
Application granted granted Critical
Publication of ATE302265T1 publication Critical patent/ATE302265T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
AT02785202T 2001-10-12 2002-10-11 Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon ATE302265T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0124580.2A GB0124580D0 (en) 2001-10-12 2001-10-12 New composition
PCT/EP2002/011428 WO2003033681A2 (en) 2001-10-12 2002-10-11 Composition comprising a lactobacillus pentosus strain and uses thereof

Publications (1)

Publication Number Publication Date
ATE302265T1 true ATE302265T1 (de) 2005-09-15

Family

ID=9923753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785202T ATE302265T1 (de) 2001-10-12 2002-10-11 Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon

Country Status (13)

Country Link
US (1) US7125708B2 (de)
EP (1) EP1436380B1 (de)
JP (2) JP3993168B2 (de)
CN (1) CN1297653C (de)
AT (1) ATE302265T1 (de)
AU (1) AU2002350530A1 (de)
BR (1) BR0213189A (de)
CA (1) CA2459572A1 (de)
DE (1) DE60205646T2 (de)
DK (1) DK1436380T3 (de)
ES (1) ES2245411T3 (de)
GB (1) GB0124580D0 (de)
WO (1) WO2003033681A2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP1481681A1 (de) * 2003-05-30 2004-12-01 Claudio De Simone Milchsäurebakterienkombination und deren Zusammensetzungen
IE20030773A1 (en) * 2003-10-17 2005-04-20 Teagasc Agric Food Dev Authori Use of probiotic bacteria in the treatment of infection
SE0400998D0 (sv) 2004-04-16 2004-04-16 Cooding Technologies Sweden Ab Method for representing multi-channel audio signals
JP4917025B2 (ja) * 2004-05-28 2012-04-18 サントリーホールディングス株式会社 ラクトバチルス・ペントーサスを含む、免疫調節作用を有する組成物
JP4515157B2 (ja) * 2004-05-28 2010-07-28 サントリーホールディングス株式会社 免疫調節作用を有する乳酸菌
JP5199551B2 (ja) * 2006-07-06 2013-05-15 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤
JP5128183B2 (ja) * 2007-05-31 2013-01-23 カゴメ株式会社 新規乳酸菌株、発酵飲食品および発酵飲食品の製造方法
AU2008259097B2 (en) * 2007-05-31 2012-12-13 Kagome Co., Ltd. Fermented food or drink product, and method for producing the same
HUP0700552A2 (en) * 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
ES2567296T3 (es) * 2008-09-17 2016-04-21 Bayer Cropscience Lp Procedimiento para usar una cepa de Bacillus subtilis para potenciar la salud animal
JP2010095465A (ja) 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
IT1397566B1 (it) 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
PT3564357T (pt) 2010-02-01 2022-06-14 Rebiotix Inc Bacterioterapia para colite por clostridium difficile
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
AU2011227226B2 (en) 2010-03-17 2017-02-16 Bayer Cropscience Lp Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
WO2012016287A2 (en) 2010-08-04 2012-02-09 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for deuvering them
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
SG10201600578UA (en) * 2011-01-25 2016-02-26 Meiji Co Ltd Gastrin Production Inhibitor and Food Composition Comprising Same
EP3610881A1 (de) 2011-03-09 2020-02-19 Regents Of The University Of Minnesota Zusammensetzungen und verfahren zur transplantation von biozönose des kolons
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
MY183171A (en) 2013-04-17 2021-02-18 Suntory Holdings Ltd Composition containing bacterium belonging to genus lactobacillus
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
PL3003330T4 (pl) 2013-06-05 2019-03-29 Rebiotix, Inc. Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzania
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
TWI643626B (zh) * 2013-08-12 2018-12-11 西班牙商巨妮亞實驗室有限公司 作為益生菌之乳桿菌屬菌株
EP3049070A4 (de) * 2013-09-27 2017-04-05 Ira Milton Trachtman Zusammensetzungen und verfahren zur behandlung und prophylaxe von erkrankungen des magen-darm-trakts
EP3294307A4 (de) 2015-05-14 2019-01-23 Crestovo Holdings Llc Zusammensetzungen zur darmfloratransplantation und verfahren zur herstellung und verwendung davon sowie verfahren zur verabreichung davon
JP6856968B2 (ja) 2015-05-22 2021-04-14 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ 自閉症スペクトラム障害および関連する症候を治療するための方法
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
ES2889902T3 (es) 2015-06-09 2022-01-14 Rebiotix Inc Métodos de fabricación de composiciones para terapia de restauración de la microbiota (TRM)
KR101761506B1 (ko) * 2015-08-13 2017-07-25 한국식품연구원 락토바실러스 펜토서스를 유효성분으로 포함하는 Th1-매개 면역 질환, Th17-매개 면역 질환, 또는 Th2-매개 면역 질환의 예방, 개선, 또는 치료용 조성물
BE1023643B1 (nl) * 2016-03-21 2017-06-01 Yun NV Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota
CN116036137A (zh) 2016-06-13 2023-05-02 株式会社村田制作所 抗菌抗病毒药物、抗菌抗病毒部件以及抗菌抗病毒药物的制造方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
BE1024425B9 (nl) * 2016-06-21 2018-03-26 Yun NV Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
CN106727870A (zh) * 2016-12-01 2017-05-31 北京伊科生态科技研究院 一种治疗酵母菌感染的复合益生菌洗液及其制备方法
AU2018250206A1 (en) 2017-04-05 2019-10-31 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (PD) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
JP2020521760A (ja) 2017-05-26 2020-07-27 クレストヴォ・ホールディングス・エルエルシー 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
CN107898815A (zh) * 2017-12-07 2018-04-13 生物源生物技术（深圳）股份有限公司 一种动物用灭活乳酸菌制剂及其用途
CN107815432B (zh) * 2017-12-07 2021-09-28 广州柏芳生物科技有限公司 一种人用灭活乳酸菌制剂及其用途
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
WO2020069280A1 (en) 2018-09-27 2020-04-02 Crestovo Holdings Llc Compositions and methods for treating epilepsy and related disorders
CN115058367B (zh) * 2022-07-06 2023-06-16 陕西省微生物研究所 一株戊糖乳杆菌(Lactobacillus pentosus)068-1及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4430M (de) * 1965-04-16 1966-09-19
GB1190386A (en) 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
EP0768375B2 (de) 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Milchbakterien
PE8795A1 (es) * 1994-01-13 1995-04-19 Nestle Sa Procedimiento para la preparacion de alimentos que tienen un contenido reducido de productos lacteos fermentados y/o material de fruta y composicion util para este
PE9795A1 (es) * 1994-01-13 1995-05-04 Nestle Sa Composicion y procedimiento util para reducir el contenido calorico graso de alimentos que contienen grasas o aceites
ECSP941055A (es) * 1994-01-13 1994-11-16 Nestle Sa Composicion y procedimiento utilizado para estabilizar proteinas de huevo sujetas a tratamiento termico subsiguiente
JP3034451B2 (ja) * 1995-09-12 2000-04-17 プリマハム株式会社 腸管由来の乳酸菌及びそれを利用した非加熱食肉製品
JPH09110707A (ja) * 1995-10-12 1997-04-28 Wakamoto Pharmaceut Co Ltd 慢性腎不全改善剤および透析患者のクオリティー オブ ライフ改善剤
JPH09263539A (ja) * 1996-03-29 1997-10-07 Nichinichi Seiyaku Kk 抗真菌作用を有する皮膚疾患治療剤
CA2280704A1 (en) 1997-02-11 1998-08-13 University College Cork Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
EP0904784A1 (de) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
WO1999017788A1 (en) 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
DE69802260T2 (de) * 1998-04-30 2002-07-04 Vesely Renata Maria Cavaliere Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
NZ513804A (en) 1999-03-11 2001-09-28 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rota viruses
AU766156B2 (en) 1999-04-02 2003-10-09 Friedshelf 339 (Proprietary) Limited Baking mixes which contain flour and have an enhanced shelf life and method and means for preparing same
EP1084709A1 (de) * 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oraler Impfstoff enthaltend rekombinanten Lactobacilli
PT1227827E (pt) 1999-10-26 2005-07-29 Nestle Sa Bacterias acido-lacticas para o tratamento e/ou profilaxia da giardiase
AUPQ415899A0 (en) 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
SG106572A1 (en) * 1999-12-02 2004-10-29 Nestle Sa Production of hydrolysate seasoning
EP1110555A1 (de) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria

Also Published As

Publication number Publication date
US20050031601A1 (en) 2005-02-10
WO2003033681A2 (en) 2003-04-24
DE60205646T2 (de) 2006-05-18
EP1436380B1 (de) 2005-08-17
JP2007308504A (ja) 2007-11-29
CA2459572A1 (en) 2003-04-24
EP1436380A2 (de) 2004-07-14
ES2245411T3 (es) 2006-01-01
GB0124580D0 (en) 2001-12-05
DK1436380T3 (da) 2005-10-17
JP3993168B2 (ja) 2007-10-17
DE60205646D1 (de) 2005-09-22
CN1297653C (zh) 2007-01-31
AU2002350530A1 (en) 2003-04-28
US7125708B2 (en) 2006-10-24
WO2003033681A3 (en) 2003-09-04
BR0213189A (pt) 2004-08-31
CN1568365A (zh) 2005-01-19
JP2005505298A (ja) 2005-02-24

Similar Documents

Publication Publication Date Title
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
FI20001460A (fi) Probiootit atooppisten sairauksien primaariseen ehkäisyyn
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
ATE421256T1 (de) Probiotische zusammensetzung
DK1539927T3 (da) Probiotisk bakterie: Lactobacillus fermentum
HUP9901619A1 (hu) Streptococcus thermophilus és bifidobacterium longum baktériumokat tartalmazó enterális diétás kompozíciók és azok alkalmazása
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
DE60208238D1 (de) Neuer lactobacillus sp.-stamm und verwendung davon
SE9702083L (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
BR0111135A (pt) Utilização de uma cepa bacteriana de espécie l. casei
IL160049A0 (en) Probiotic lactobacillus salivarius strains
DE60237645D1 (de) Immunstimulierendes Mittel enthaltend eine Biomasse von methanotrophem Bakterium
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
DE60214029D1 (de) Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs
EP1607096A3 (de) Nutrazeutische Zusammensetzungen enthaltend Milchenzyme als Symbiose
Colbert et al. The Effects Probiotics Have on The Oral Cavity
RU2003112420A (ru) Биопрепарат лечебно-профилактического действия при эндометритах животных
BG105453U (en) Probiotic food additive
AR045293A1 (es) Un promotor de crecimiento a base de la bacteria "bacillus megatherium" para aplicar en agricultura y el metodo para su desarrollo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1436380

Country of ref document: EP

REN Ceased due to non-payment of the annual fee